Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76551 - 76575 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tamibarotene	Investigational	PLEK	5341	upregulated	tamibarotene results in increased expression of PLEK mRNA	2p14	A24376 A20516
Tamibarotene	Investigational	PLK4	10733	downregulated	tamibarotene results in decreased expression of PLK4 mRNA	4q28.1	A24376
Tamibarotene	Investigational	PLSCR1	5359	upregulated	tamibarotene results in increased expression of PLSCR1 mRNA	3q24	A24376
Tamibarotene	Investigational	PLXNA1	5361	upregulated	tamibarotene results in increased expression of PLXNA1 mRNA	3q21.3	A20516
Tamibarotene	Investigational	PNN	5411	downregulated	tamibarotene results in decreased expression of PNN mRNA	14q21.1	A24376
Tamibarotene	Investigational	POLD4	57804	upregulated	tamibarotene results in increased expression of POLD4 mRNA	11q13.2	A24376
Tamibarotene	Investigational	POR	5447	upregulated	tamibarotene results in increased expression of POR mRNA	7q11.23	A24376
Tamibarotene	Investigational	PPAT	5471	downregulated	tamibarotene results in decreased expression of PPAT mRNA	4q12	A24376
Tamibarotene	Investigational	PPFIA1	8500	downregulated	tamibarotene results in decreased expression of PPFIA1 mRNA	11q13.3	A24376
Tamibarotene	Investigational	PPP1CB	5500	downregulated	tamibarotene results in decreased expression of PPP1CB mRNA	2p23.2	A24376
Tamibarotene	Investigational	PPP1R15A	23645	upregulated	tamibarotene results in increased expression of PPP1R15A mRNA	19q13.2	A20516
Tamibarotene	Investigational	PRKACA	5566	upregulated	tamibarotene results in increased expression of PRKACA mRNA	19p13.1	A20516
Tamibarotene	Investigational	PRKACB	5567	downregulated	tamibarotene results in decreased expression of PRKACB mRNA	1p31.1	A24376
Tamibarotene	Investigational	PRKCB	5579	upregulated	tamibarotene results in increased expression of PRKCB mRNA	16p12.2-p12.1	A24376
Tamibarotene	Investigational	PRKCD	5580	upregulated	tamibarotene results in increased expression of PRKCD mRNA	3p21.1	A24376
Tamibarotene	Investigational	PRKCI	5584	downregulated	tamibarotene results in decreased expression of PRKCI mRNA	3q26.2	A24376
Tamibarotene	Investigational	PRKDC	5591	downregulated	tamibarotene results in decreased expression of PRKDC mRNA	8q11.21	A24376
Tamibarotene	Investigational	PRMT2	3275	upregulated	tamibarotene results in increased expression of PRMT2 mRNA	21q22.3	A24376
Tamibarotene	Investigational	PRRC2C	23215	downregulated	tamibarotene results in decreased expression of PRRC2C mRNA	1q24.3	A24376
Tamibarotene	Investigational	PRTN3	5657	upregulated	tamibarotene results in increased expression of PRTN3 mRNA	19p13.3	A20516
Tamibarotene	Investigational	PSMB9	5698	upregulated	tamibarotene results in increased expression of PSMB9 mRNA	6p21.32	A24376
Tamibarotene	Investigational	PSME2	5721	upregulated	tamibarotene results in increased expression of PSME2 mRNA	14q12	A24376
Tamibarotene	Investigational	PTK2B	2185	upregulated	tamibarotene results in increased expression of PTK2B mRNA	8p21.2	A24376
Tamibarotene	Investigational	PTPRC	5788	downregulated	tamibarotene results in decreased expression of PTPRC mRNA	1q31.3-q32.1	A20516
Tamibarotene	Investigational	PTPRF	5792	downregulated	tamibarotene results in decreased expression of PTPRF mRNA	1p34.2	A24376

Displaying entries 76551 - 76575 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability